---
title: "Very low‑calorie diet reduces hepatic steatosis and remodels circulating metabolite–miRNA networks"
id: "medrxiv-1-very-low-calorie-diet-reduces-hepatic-steatosis-and-remodels-circulating"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-1-very-low-calorie-diet-reduces-hepatic-steatosis-and-remodels-circulating"
content_type: "clinical_feed_article"
specialty: "Gastroenterology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.01.26361664v1?rss=1"
published_at: "2026-09-04T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Very low‑calorie diet reduces hepatic steatosis and remodels circulating metabolite–miRNA networks
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-1-very-low-calorie-diet-reduces-hepatic-steatosis-and-remodels-circulating
- **Specialty:** [Gastroenterology](https://medichelpline.com/clinical-feed/gastroenterology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.01.26361664v1?rss=1)
- **Published At:** 2026-09-04T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Pilot study of an 8‑week **very low‑calorie diet (VLCD)** in women with obesity and metabolic dysfunction‑associated steatotic liver disease (MASLD) but without diabetes. The trial is registered as NCT04861571 and received IRB approval from the University of Iowa. - VLCD produced substantial weight loss (~11%) with approximately **80% adherence** and was reported as well tolerated. - Significant improvements were observed in body composition and cardiometabolic measures: reduced fat mass, smaller waist circumference, lower blood pressure, decreased insulinemia, improved HOMA‑IR, lower HbA1c, and reduced triglycerides. Liver enzyme levels did not change. - Hepatic steatosis decreased markedly as measured by a fall in **controlled attenuation parameter (CAP)**; liver stiffness remained unchanged. - Untargeted metabolomics showed elevated **ketone bodies** and broad reductions in circulating amino acids, consistent with increased fatty acid oxidation and a catabolic state. - Correlation analyses linked CAP improvements positively with reductions in amino acids and negatively with increases in ketone bodies and tricarboxylic acid (TCA) cycle intermediates. - Circulating microRNAs underwent selective remodeling; a limited subset changed strongly and associated with clinical metrics including CAP and HOMA‑IR. VLCD altered levels of **miR‑148a‑3p, miR‑140‑3p, miR‑10b‑5p,** and **miR‑345‑5p**. - Integrated multi‑omics identified coordinated metabolite–miRNA modules involving glucose metabolism, branched‑chain amino acid catabolism, mitochondrial metabolism, purine metabolism, microbial metabolites, and cellular redox pathways. - Authors conclude that VLCD‑induced improvement in hepatic steatosis is accompanied by coordinated remodeling of circulating metabolite–miRNA networks and propose these modules as candidate biomarkers of therapeutic response. - No competing interests declared. All study data are available from the authors on reasonable request.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=iJNdfhndUSG5Yt_RGKiKG81.Dj9JfckGqa5gq4kjKzk-1788566848.3688579-1.2.1.1-DZ91XIACvUwygfa3uya6LUuheAkieDypuAEeaDSsuFjP4emnz1hr26GlvX3oObDY) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.09.01.26361664v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Very low-calorie diet reduces hepatic steatosis and remodels circulating metabolite-microRNAs networks in metabolic dysfunction-associated steatotic liver disease: A pilot study Paroma Deb, Darin Bagar, Prashant Kumar, Leon Sun, Ethan Chen, Ravinder Reddy Gaddam, Lorrana F Ferretto, Constance R Shelsky, Antonio J Sanchez, Himani Thakkar, Bhagirath Chaurasia, Ajit Vikram, Marcelo Lima DG Correia doi: https://doi.org/10.64898/2026.09.01.26361664 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Paroma Deb University of Iowa * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Paroma%2BDeb%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Deb%20P&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AParoma%2BDeb%2B) Darin Bagar University of Iowa * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Darin%2BBagar%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Bagar%20D&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ADarin%2BBagar%2B) Prashant Kumar University of Iowa * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Prashant%2BKumar%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Kumar%20P&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3APrashant%2BKumar%2B) Leon Sun University of Iowa * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Leon%2BSun%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Sun%20L&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ALeon%2BSun%2B) Ethan Chen University of Iowa * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Ethan%2BChen%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Chen%20E&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AEthan%2BChen%2B) Ravinder Reddy Gaddam University of Iowa * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Ravinder%2BReddy%2BGaddam%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Gaddam%20RR&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ARavinder%2BReddy%2BGaddam%2B) Lorrana F Ferretto University of Iowa * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Lorrana%2BF%2BFerretto%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Ferretto%20LF&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ALorrana%2BF%2BFerretto%2B) Constance R Shelsky University of Iowa * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Constance%2BR%2BShelsky%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Shelsky%20CR&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AConstance%2BR%2BShelsky%2B) Antonio J Sanchez University of Iowa * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Antonio%2BJ%2BSanchez%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Sanchez%20AJ&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAntonio%2BJ%2BSanchez%2B) Himani Thakkar University of Iowa * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Himani%2BThakkar%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Thakkar%20H&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AHimani%2BThakkar%2B) Bhagirath Chaurasia University of Iowa * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Bhagirath%2BChaurasia%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Chaurasia%20B&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ABhagirath%2BChaurasia%2B) Ajit Vikram University of Iowa * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Ajit%2BVikram%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Vikram%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAjit%2BVikram%2B) * For correspondence: ajit-vikram@uiowa.edu Marcelo Lima DG Correia University of Iowa * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Marcelo%2BLima%2BDG%2BCorreia%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Correia%20ML&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMarcelo%2BLima%2BDG%2BCorreia%2B) * [Abstract](https://www.medrxiv.org/content/10.64898/2026.09.01.26361664v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1292947/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.09.01.26361664v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1292947/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.09.01.26361664v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1292947/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.09.01.26361664v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1292947/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.09.01.26361664v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1292947/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Metabolic dysfunction-associated steatotic liver disease (MASLD) is a major cause of chronic liver disease, with weight loss as the pivotal therapeutic strategy. However, the metabolic and molecular adaptations underlying rapid weight loss remain incompletely defined. In this pilot study, women with obesity and MASLD but without diabetes consumed a very low-calorie diet (VLCD) for 8 weeks. Clinical parameters, hepatic steatosis measured by controlled attenuation parameter (CAP), circulating metabolites, and microRNAs (miRs) were assessed before and after the dietary intervention. Integrated correlation and hierarchical clustering analyses were performed to identify molecular networks associated with clinical improvement. VLCD was well tolerated, resulting in significant weight loss (~11%) with ~80% adherence. Significant improvements in metabolic parameters were observed, including fat mass, waist circumference, blood pressure, insulinemia, HOMA-IR, HbA1c, and triglycerides, with unchanged liver enzymes. Hepatic steatosis decreased markedly, as indicated by a reduction in CAP, while stiffness remained unchanged. Metabolomic profiling revealed elevated ketone bodies and broad reductions in amino acid levels, consistent with enhanced fatty acid oxidation and a catabolic metabolic state. Correlation analysis identified distinct metabolite signatures associated with hepatic steatosis, with changes in CAP positively associated with changes in amino acids and inversely associated with changes in ketone bodies and tricarboxylic acid cycle intermediates. Circulating miRs underwent selective rather than global remodeling, with only a limited subset showing strong associations with clinical parameters, including CAP and HOMA-IR. Specifically, VLCD altered the circulating levels of miR-148a-3p, miR-140-3p, miR-10b-5p, and miR-345-5p. Integration of metabolomic and miR datasets identified coordinated metabolite-miR modules involving glucose metabolism, branched-chain amino acid catabolism, mitochondrial metabolism, purine metabolism, microbial metabolites, and cellular redox pathways. These findings demonstrate that improvement in hepatic steatosis during VLCD-induced weight loss is accompanied by coordinated remodeling of circulating metabolite-miR networks. Integrated multi-omics analysis identifies candidate molecular signatures associated with metabolic adaptation and highlights circulating miR-metabolite modules as potential biomarkers of therapeutic response in MASLD. ### Competing Interest Statement The authors have declared no competing interest. ### Clinical Trial NCT04861571 ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: IRB committee of The University of Iowa gave ethical approval for this work. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability All data produced in the present study are available upon reasonable request to the authors. Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.09.01.26361664v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.08.31.26361636v1 "Rest-activity and circadian rhythm parameters relate to cognition and disability outcomes in multiple sclerosis")[Next ](https://www.medrxiv.org/content/10.64898/2026.09.01.26361966v1 "Cell-type-resolved somatic variant discovery from bulk long-read sequencing") Posted September 04, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.09.01.26361664v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/09/04/2026.09.01.26361664.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.09.01.26361664v1#p-5) [ Data/Code](https://www.medrxiv.org/content/early/2026/09/04/2026.09.01.26361664.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Very low-calorie diet reduces hepatic steatosis and remodels circulating metabolite-microRNAs networks in metabolic dysfunction-associated steatotic liver disease: A pilot study Paroma Deb, Darin Bagar, Prashant Kumar, Leon Sun, Ethan Chen, Ravinder Reddy Gaddam, Lorrana F Ferretto, Constance R Shelsky, Antonio J Sanchez, Himani Thakkar, Bhagirath Chaurasia, Ajit Vikram, Marcelo Lima DG Correia medRxiv 2026.09.01.26361664; doi: https://doi.org/10.64898/2026.09.01.26361664 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.01.26361664v1%26text%3DVery%2520low-calorie%2520diet%2520reduces%2520hepatic%2520steatosis%2520and%2520remodels%2520circulating%2520metabolite-microRNAs%2520networks%2520in%2520metabolic%2520dysfunction-associated%2520steatotic%2520liver%2520disease%253A%2520A%2520pilot%2520study "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.01.26361664v1%26t%3DVery%2520low-calorie%2520diet%2520reduces%2520hepatic%2520steatosis%2520and%2520remodels%2520circulating%2520metabolite-microRNAs%2520networks%2520in%2520metabolic%2520dysfunction-associated%2520steatotic%2520liver%2520disease%253A%2520A%2520pilot%2520study "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.01.26361664v1%26title%3DVery%2520low-calorie%2520diet%2520reduces%2520hepatic%2520steatosis%2520and%2520remodels%2520circulating%2520metabolite-microRNAs%2520networks%2520in%2520metabolic%2520dysfunction-associated%2520steatotic%2520liver%2520disease%253A%2520A%2520pilot%2520study%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.01.26361664v1%26title%3DVery%2520low-calorie%2520diet%2520reduces%2520hepatic%2520steatosis%2520and%2520remodels%2520circulating%2520metabolite-microRNAs%2520networks%2520in%2520metabolic%2520dysfunction-associated%2520steatotic%2520liver%2520disease%253A%2520A%2520pilot%2520study "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.09.01.26361664) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.09.01.26361664v1&count=horizontal&via=&text=Very%20low-calorie%20diet%20reduces%20hepatic%20steatosis%20and%20remodels%20circulating%20metabolite-microRNAs%20networks%20in%20metabolic%20dysfunction-associated%20steatotic%20liver%20disease%3A%20A%20pilot%20study&counturl=www.medrxiv.org/content/10.64898/2026.09.01.26361664v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (615) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (896) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (327) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4777) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (476) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (410) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (645) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1617) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (15853) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (32) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1196) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (6996) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (727) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1059) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (4999) * [Health Policy](https://www.medrxiv.org/collection/health
## Related Clinical Research

- [Fauci on pandemic memory: selective amnesia and its effect on views of masking and lockdowns](https://medichelpline.com/clinical-feed/stat-news-1-stat-fauci-speaks-and-writes.md)
- [FDA’s Biologics Branch Acts Against Unproven Stem Cell Clinics: A Surprising Regulatory Win](https://medichelpline.com/clinical-feed/stat-news-1-opinion-stat-a-surprising-bright-spot-at-the-fda-on-regulating-unproven-stem.md)
- [Waist circumference predicts mortality more than BMI in adults 65+: study findings](https://medichelpline.com/clinical-feed/medical-news-today-0-bmi-vs-waist-size-study-finds-belly-fat-matters-more-than-weight-for-death-risk.md)
- [Early Multiple Sclerosis Shows Greater Reliance on Mediolateral CoM Velocity for Foot Placement Co](https://medichelpline.com/clinical-feed/medrxiv-2-stability-related-foot-placement-control-relies-more-on-mediolateral-center-of.md)
- [Keto Diet Shows Superior Metabolic Benefits Over Mediterranean and Low-Fat Diets](https://medichelpline.com/clinical-feed/medical-news-today-1-keto-diet-may-have-metabolic-advantages-over-mediterranean-low-fat-diets.md)

## Navigation
- [← Back to Gastroenterology Feed](https://medichelpline.com/clinical-feed/gastroenterology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.